These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 1974298
1. The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA). Barrand MA, Hider RC, Callingham BA. J Pharm Pharmacol; 1990 Apr; 42(4):279-82. PubMed ID: 1974298 [Abstract] [Full Text] [Related]
2. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat. Barrand MA, Callingham BA. Br J Pharmacol; 1991 Feb; 102(2):408-14. PubMed ID: 2015422 [Abstract] [Full Text] [Related]
4. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat. Barrand MA, Callingham BA, Dobbin P, Hider RC. Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845 [Abstract] [Full Text] [Related]
5. Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate. Singh RK, Barrand MA. J Pharm Pharmacol; 1990 Apr; 42(4):276-9. PubMed ID: 1974297 [Abstract] [Full Text] [Related]
6. Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test. Kelsey SM, Hider RC, Bloor JR, Blake DR, Gutteridge CN, Newland AC. J Clin Pharm Ther; 1991 Apr; 16(2):117-22. PubMed ID: 1856249 [Abstract] [Full Text] [Related]
7. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine. Barrand MA, Callingham BA, Hider RC. J Pharm Pharmacol; 1987 Mar; 39(3):203-11. PubMed ID: 2883285 [Abstract] [Full Text] [Related]
8. Absorption of ferric maltol, a novel ferric iron compound, in iron-deficient subjects. Kelsey SM, Blake DR, Hider RC, Gutteridge CN, Newland AC. Clin Lab Haematol; 1989 Mar; 11(3):287-8. PubMed ID: 2591161 [No Abstract] [Full Text] [Related]
9. Dependence of intestinal iron absorption on the valency state of iron. Wollenberg P, Rummel W. Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):578-82. PubMed ID: 3125486 [Abstract] [Full Text] [Related]
10. The host-protein-independent iron uptake by Tritrichomonas foetus. Tachezy J, Suchan P, Schrével J, Kulda J. Exp Parasitol; 1998 Oct; 90(2):155-63. PubMed ID: 9769245 [Abstract] [Full Text] [Related]
11. Lipid peroxidation stimulated by iron nitrilotriacetate in rat liver. Goddard JG, Basford D, Sweeney GD. Biochem Pharmacol; 1986 Jul 15; 35(14):2381-7. PubMed ID: 3729994 [Abstract] [Full Text] [Related]
12. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency. Bokemeyer B, Krummenerl A, Maaser C, Howaldt S, Mroß M, Mallard N. Eur J Drug Metab Pharmacokinet; 2017 Apr 15; 42(2):229-238. PubMed ID: 27101422 [Abstract] [Full Text] [Related]
13. Non-transferrin iron uptake by trophoblast cells in culture. Significance of a NADH-dependent ferrireductase. Verrijt CE, Kroos MJ, Huijskes-Heins MI, van Eijk HG, van Dijk JP. Placenta; 1998 Sep 15; 19(7):525-30. PubMed ID: 9778126 [Abstract] [Full Text] [Related]
14. Peroxide-dependent and -independent lipid peroxidations catalyzed by chelated iron. Fukuzawa K, Fujii T, Mukai K. Arch Biochem Biophys; 1991 Nov 01; 290(2):489-96. PubMed ID: 1656881 [Abstract] [Full Text] [Related]
15. Tissue distribution of gallium following administration of the gallium-maltol complex in the rat: a model for an aluminium-maltol complex of neurotoxicological interest. Farrar G, Morton AP, Blair JA. Food Chem Toxicol; 1988 Jun 01; 26(6):523-5. PubMed ID: 3169652 [Abstract] [Full Text] [Related]
16. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate. Hamazaki S, Okada S, Li JL, Toyokuni S, Midorikawa O. Arch Biochem Biophys; 1989 Jul 01; 272(1):10-7. PubMed ID: 2500058 [Abstract] [Full Text] [Related]
17. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes. Heinrich HC. Arzneimittelforschung; 1975 Mar 01; 25(3):420-6. PubMed ID: 1174047 [Abstract] [Full Text] [Related]